芪苈强心胶囊加ACEI与β受体阻滞剂治疗慢性心衰80例

Qiliqiangxin capsule combined with ACEI and β-blocker in the treatment of 80 cases of chronic heart failure

目的:观察芪苈强心胶囊加血管紧张素转换酶抑制剂(ACEI)与β受体阻滞剂治疗慢性心力衰竭的效果。方法:收治慢性心力衰竭患者160例,随机分为两组,各80例。治疗组在规范西医治疗基础上加芪苈强心胶囊;对照组采用规范西医常规治疗。比较两组治疗效果。结果:治疗组患者酒石酸美托洛尔及卡托普利达标率高于对照组,差异有统计学意义(P<0.05)。结论:慢性心力衰竭治疗中加用芪苈强心胶囊改善心功能的同时可以使ACEI及β受体阻滞剂的耐受性进一步提高,在心衰治疗中达到推荐剂量者相应增加,从而提高患者远期生存率。

Objective:To observe the effects of Qiyingqiangxin capsule combined wit angiotensin-converting enzyme inhibitor(ACEI)and β-blocker in the treatment of chronic heart failure.Methods:160 patients with chronic heart failure were selected,they were randomly divided into the two groups with 80 cases in each group.In the treatment group,qiliqiangxin capsule was added on the basis of standardized western medicine treatment,in the control group,conventional western medicine treatment was used.We compared the therapeutic effect of the two groups.Results:The rate of compliance with metoprolol tartrate and captopril was higher in the treatment group than in the control group,the difference was statistically significant(P<0.05).Conclusion:Qiliqiangxin capsule can improve the heart function and the tolerance of ACEI andβ-blocker in the treatment of chronic heart failure,in the treatment of heart failure,those who reach the recommended dose will increase correspondingly,so as to improve the long-term survival rate of patients.